Change In Spherical Equivalent Refractive Error Research Articles

Baseline factors associated with myopia progression and axial elongation over 30 months in children 5 to 12 years of age.

This study aimed to identify baseline factors associated with greater myopia progression and axial elongation in children with myopia. This study performed a post hoc analysis of data from a 30-month randomized trial of atropine 0.01% versus placebo in children 5 to <13 years old with baseline spherical equivalent refractive error (SER) of -1.00 to -6.00 D, astigmatism of ≤1.50 D, and anisometropia of <1.00 D SER. Data from atropine 0.01% and placebo groups were pooled given outcomes were similar. Baseline factors of age, SER, axial length, race, sex, parental myopia, and iris color were evaluated for association with changes in SER and with changes in axial length at 30 months (24 months on treatment and then 6 months off) using backward model selection. Among 187 randomized participants, 175 (94%) completed 30 months of follow-up. The mean change in SER was greater among younger children (-0.19 D per 1 year younger; 95% confidence interval [CI], -0.25 to -0.14 D; p<0.001) and children with higher myopia (-0.14 D per 1 D more myopia at baseline; 95% CI, -0.23 to -0.05 D; p=0.002). The mean change in axial length was also greater among younger children (0.13 mm per 1 year younger; 95% CI, 0.10 to 0.15 mm; p<0.001) and children with higher baseline myopia (0.04 mm per 1 D more myopia; 95% CI, 0.002 to 0.08; p=0.04). Younger children with higher myopia had greater myopic progression and axial elongation over 30 months than older children with lower myopia. Developing effective treatments to slow the faster myopic progression in younger children should be a target of further research.

The effect of individualized ocular refraction customized spectacle lenses on myopia control in schoolchildren: A 1-year randomised clinical trial.

The aim of this study was to investigate the effect of individualized ocular refraction customized (IORC) spectacle lenses with different actual amounts of peripheral myopic defocus (MD) on myopia control over 1 year. These lenses compensate for the original peripheral refraction via the free-form surface on the back of the lens. This 1-year, double-masked randomised clinical trial included 184 myopic schoolchildren aged 8-12 years. Participants were randomised to receive IORC lenses with high (IORC-H group, +4.50 D), medium (IORC-M group, +3.50 D) or low (IORC-L group, +2.50 D) MD or single-vision (SV) lenses. The spherical equivalent refractive error (SER) and axial length (AL) were measured at baseline and 6-monthly intervals. After 1 year, the mean (SD) changes in SER were -0.18 (0.37), -0.36 (0.37), -0.52 (0.39) and -0.60 (0.42) D for the IORC-H, IORC-M, IORC-L and SV groups, respectively. Compared with the SV group, the effects of slowing myopia progression were 70%, 40% and 13% for the IORC-H (difference of 0.47 D, p < 0.001), IORC-M (difference of 0.32 D, p = 0.001) and IORC-L (difference of 0.15 D, p > 0.05) groups, respectively. The mean (SD) changes in AL were 0.12 (0.16), 0.23 (0.17), 0.29 (0.17) and 0.36 (0.17) mm for the IORC-H, IORC-M, IORC-L and SV groups, respectively. The axial elongation was 67%, 36% and 19% lower in the IORC-H (difference of 0.25 mm, p < 0.001), IORC-M (difference of 0.15 mm, p < 0.001) and IORC-L (difference of 0.10 mm, p = 0.04) groups, respectively, compared with the SV group. The IORC-H group exhibited significantly less axial elongation than the IORC-M and IORC-L groups (p = 0.01 and p < 0.001, respectively). Compared with the IORC-M and IORC-L lenses, the IORC-H lens was found to have superior efficacy in inhibiting myopic progression and slowing eye growth in schoolchildren, with better myopia control efficacy in younger children.

Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia

Increased myopic shift was found to be associated with 1 year of overminus spectacle treatment for children with intermittent exotropia (IXT). Persistence of myopic shift after discontinuing overminus spectacles is unknown. To compare refractive error change over 3 years in children with IXT originally treated with overminus vs nonoverminus spectacles. This study was an 18-month extension of the Trial of Overminus Spectacle Therapy for Intermittent Exotropia cohort, which previously randomized children aged 3 to 10 years with IXT and baseline spherical equivalent refractive error (SER) between -6.00 diopters (D) and 1.00 D to overminus spectacles (-2.50 D for 12 months, -1.25 D for 3 months, and nonoverminus for 3 months) or nonoverminus spectacles. Children were recruited from 56 sites from July 2010 to February 2022. Data were analyzed from February 2022 to January 2024. After trial completion at 18 months, participants were followed up at 24 and 36 months. Treatment was at investigator discretion from 18 to 36 months. Change in SER (cycloplegic retinoscopy) from baseline to 36 months. Of 386 children in the Trial of Overminus Spectacle Therapy for Intermittent Exotropia, 223 (57.8%) consented to 18 months of additional follow-up, including 124 of 196 (63.3%) in the overminus treatment group and 99 of 190 (52.1%) in the nonoverminus treatment group. Of 205 children who completed 36-month follow-up, 116 (56.6%) were female, and the mean (SD) age at randomization was 6.2 (2.1) years. Mean (SD) SER change from baseline to 36 months was greater in the overminus group (-0.74 [1.00] D) compared with the nonoverminus group (-0.44 [0.85] D; adjusted difference, -0.36 D; 95% CI, -0.59 to -0.12; P = .003), with 30 of 112 (26.8%) in the overminus group having more than 1 D of myopic shift compared with 14 of 91 (15%) in the nonoverminus group (risk ratio, 1.8; 95% CI, 1.0-3.0). From 12 to 36 months, mean (SD) myopic shift was -0.34 (0.67) D and -0.36 (0.66) D in the overminus and nonoverminus groups, respectively (adjusted difference, -0.001 D; 95% CI, -0.18 to 0.18; P = .99). The greater myopic shift observed after 1 year of -2.50-D overminus lens treatment remained at 3 years. Both groups had similar myopic shift during the 2-year period after treatment weaning and cessation. The risk of myopic shift should be discussed with parents when considering overminus lens treatment. ClinicalTrials.gov Identifier: NCT02807350.

Center-for-Near Extended-Depth-of-Focus Soft Contact Lens for Myopia Control in Children: 1-Year Results of a Randomized Controlled Trial.

IntroductionThis study aimed to assess the safety and efficacy of a novel extended-depth-of-focus (EDOF) soft contact lens for myopia control in children.MethodsA prospective, multicenter, randomized, double-masked, placebo-controlled, contralateral-eye comparison clinical trial was conducted in 72 children (40 male and 32 female) aged 9 to 14 years, with each eye randomly selected to wear either an experimental EDOF contact lens or a single-vision control lens at least 8 h per day, 5 days a week, for 52 weeks. Each contact lens was worn and then replaced daily. Measurements including best-corrected visual acuity, spherical equivalent refractive error (SER), axial length (AXL), and keratometry were performed at weeks 1, 4, and 13, and every 13 weeks thereafter for 52 weeks. The primary outcome measure was the change in SER, measured using cycloplegic auto-refraction. The secondary outcome measure was the change in AXL.ResultsAt week 52, the mean change in SER was significantly lower with the experimental lens (−0.70 ± 0.49 D) than with the control lens (−0.88 ± 0.51 D; P < .001). The mean AXL elongation was significantly lower with the experimental lens (0.34 ± 0.19 mm) than with the control lens (0.38 ± 0.19 mm; P < .001). The EDOF lens reduced AXL and myopia progression by 10.5% and 20.5%, respectively. The change in SER, but no AXL, was significantly associated with EDOF lens wear in adjusted multivariate regression analysis. Reported adverse events did not differ significantly between the two lens types.ConclusionsThe results of this 1-year clinical trial demonstrate that the experimental EDOF soft contact lens slows myopia progression and reduces AXL elongation in children compared with a single-vision contact lens. (This study was retrospectively registered with ClinicalTrials.gov; identifier: NCT04238897; date of registration: January 23, 2020.)

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial

Four hundred myopic children randomly received atropine 0.02% (n = 138) or 0.01% (n = 142) in both eyes once-nightly or only wore single-vision spectacles (control group) (n = 120) for 2 years. Spherical equivalent refractive error (SER), axial length (AL), pupil diameter (PD), and amplitude of accommodation (AMP) were measured every 4 months. After 2 years, the SER changes were − 0.80 (0.52) D, − 0.93 (0.59) D and − 1.33 (0.72) D and the AL changes were 0.62 (0.29) mm, 0.72 (0.31) mm and 0.88 (0.35) mm in the 0.02% and 0.01% atropine groups and control group, respectively. There were significant differences between changes in SER and AL in the three groups (all P < 0.001). The changes in SER and AL in the 2nd year were similar to the changes in the 1st year in the three groups (all P > 0.05). From baseline to 2 years, the overall decrease in AMP and increase in PD were not significantly different in the two atropine groups, whereas the AMP and PD in the control group remained stable (all P > 0.05). 0.02% atropine had a better effect on myopia control than 0.01% atropine, and its effects on PD and AMP were similar to 0.01% atropine. 0.02% or 0.01% atropine controlled myopia progression and AL elongation synchronously and had similar effects on myopia control each year.

The relationship between myopia progression and axial elongation in children wearing orthokeratology contact lenses

PurposeTo investigate the relationship between myopia progression and axial length (AL) elongation in orthokeratology (ortho-k) patients. MethodsThis study investigated 184 patients (baseline age 9.0 ± 1.6 years), who underwent overnight ortho-k treatment for 12 to 72 months, and stopped lens wear for 1 to 2 months. Refractive sphere and cylinder after cycloplegia, corneal curvatures along both meridians, and AL were compared before the commencement and after discontinuation of ortho-k treatment. The effects of AL change, baseline AL, corneal curvature change, baseline age, and duration of ortho-k treatment on the change in spherical equivalent refractive error (SER) were analysed. ResultsMyopia significantly progressed and AL increased following 32.8 ± 13.0 months of ortho-k lens wear and 1 to 2 months washout period, as compared to baseline (all P < 0.001). Corneal curvature along the flat meridian (FK) became significantly flatter (P < 0.001) and corneal curvature along the steep meridian (SK) became steeper (P = 0.036). In the first stepwise multiple linear regression model (R2 = 0.696), the change in SER over time (ΔSER) is significantly correlated to the change in AL (ΔAL, P < 0.001), baseline AL (P < 0.001), baseline age (P = 0.028), change in SK (P = 0.002), and the duration of ortho-k lens treatment before discontinuation (P = 0.010). In a more simplified model (R2 = 0.628), the regression equation using ΔAL to predict ΔSER is: ΔSER = -0.094–1.608*ΔAL. ConclusionsThe change in SER was significantly correlated to the change in AL, change in SK, baseline AL, baseline age, and the duration of treatment among children undergoing ortho-k therapy. The ratio of axial elongation to myopia progression was approximately 1:1.6 between the ages of 6 to 14 years. A simplified equation was derived for clinical use to estimate myopia progression from repeated AL measurement in ortho-k patients.

Short-term refractive and ocular parameter changes after topical atropine.

PURPOSE:The purpose of this study is to explore short-term refractive and ocular parameter changes and their correlations after cycloplegia with atropine.METERIALS AND METHODS:This is a prospective clinical trial that enrolled 96 eyes of 96 participants (mean age, 8.5 ± 2.1 years). Spherical equivalent refractive error (SER), axial length (AL), mean keratometric value (mean-K), anterior chamber depth (ACD), and intraocular pressure (IOP) were measured at baseline and 1 week after topical use of 0.125% atropine. Postcycloplegic changes of refractive error and ocular parameters were evaluated, and their correlations were analyzed with multiple linear regression models.RESULTS:After topical atropine use, the mean AL decreased by 0.016 mm (P = 0.008), and the mean ACD increased by 0.58 mm (P < 0.0001). There was no significant change in the Mean-K or IOP. Eighty-two eyes (85%) had an emmetropic or hyperopic shift, and 14 (15%) had a myopic shift. Those with an emmetropic or hyperopic shift had their mean AL shortened by 0.023 mm, whereas the eyes with myopic shifts had their mean AL lengthened by 0.026 mm (P = 0.003). Change in SER was negatively correlated with change in AL (−2.57 D for an increase of 1 mm in AL, P < 0.001) and positively correlated with change in ACD (+0.96 D for an increase of 1 mm in ACD, P = 0.013).CONCLUSION:Most eyes had emmetropic or hyperopic changes after short-term topical atropine use, and AL shortening and anterior chamber deepening both contributed to the hyperopic changes. Meanwhile, myopic change may be observed in some eyes (15%), which were related to transient AL elongation but not invalid myopic control. This encouraged clinicians to sustain the atropine treatment for a longer period before switching to other modalities for myopic control in clinical practice.The clinical trial registration number NCT03839888 (clinicaltrials.gov).

Longitudinal Changes in Refractive Error in a Pediatric Referral Population in Korea.

To investigate changes in the spherical equivalent (SE) refractive error and astigmatism in a pediatric referral population in Korea with longitudinal follow-up and to evaluate the effect of risk factors on changes in refractive error. This was a retrospective case series. In total, 221 patients who presented to a tertiary care hospital when aged 3 to 9 years and who underwent at least 10 years of follow-up were enrolled. The patients were divided into groups in terms of the initial extent of SE refractive error, the initial extent of astigmatism, sex, and ocular alignment. Changes in SE and astigmatism were compared among the groups. The patients were followed up for a mean of 11.19 ± 1.81 years. An overall negative shift in SE refractive error and increasing tendency in astigmatism during the follow-up period were noted. The negative shift in SE refractive error in the myopia group was significantly greater than those in the emmetropia and hyperopia groups. The change in astigmatism in the myopia group was significantly greater than that in the hyperopia group. The change in astigmatism in the low astigmatism group was significantly greater than those in the moderate and high astigmatism groups. Sex did not influence the changes in SE refractive error or astigmatism. A pediatric referral population in Korea showed a negative shift in SE refractive error and increasing tendency in astigmatism during childhood. Changes in refractive error may be influenced by the initial degree of SE refractive error and astigmatism. [J Pediatr Ophthalmol Strabismus. 2017;54(1):43-51.].

Long-Term Changes in Refractive Error in Children With Myopic Tilted Optic Disc Compared to Children Without Tilted Optic Disc

To compare changes in the spherical equivalent (SE) refractive error between children with and without myopic tilted optic disc. Changes in SE refractive error were compared between a group of 88 children with -1.5 diopters or more of myopia with myopic tilted disc and a group of 108 age- and initial SE refractive error-matched children without tilted disc. Factors that significantly influenced changes in SE refractive error were analyzed using mixed models. Patients in the myopic tilted disc group were followed for 5.3 ± 3.1 years, on average, and patients in the nontilted disc group were followed for an average of 5.3 ± 2.3 years. An overall tendency toward myopic progression during the follow-up period was noted in both groups. According to univariate analysis, patients with a poorer baseline best-corrected visual acuity (BCVA) and tilted discs tended to have greater myopia over time (P < 0.001 and P = 0.009, respectively). Myopic progression in the tilted disc group was significantly greater than that in the nontilted disc group (P < 0.001) after adjusting for sex and initial BCVA. Patients with myopic disc tilt showed greater myopic progression over time. These data suggest that myopic disc tilt represents a prognostic factor for further myopic progression, but it is unclear whether the disc tilt directly affects the progression rate of myopia or is a noncontributory consequence of other underlying mechanisms. The temporal relationship between the onset of the disc tilt and the myopic progression should be further studied using a prospective design.

A Prospective Study of Spherical Refractive Error and Ocular Components Among Northern Irish Schoolchildren (The NICER Study)

To explore 3-year change in spherical refractive error and ocular components among white Northern Irish schoolchildren. Baseline data were collected among 6- to 7-year-old and 12- to 13-year-old children. Three years after baseline, follow-up data were collected. Cycloplegic refractive error and ocular components measurements (axial length [AL], anterior chamber depth [ACD], corneal radius of curvature [CRC]) were determined using binocular open-field autorefraction and ocular biometry. Change in spherical equivalent refractive error (SER) and ocular components were calculated. A statistically significantly greater change in SER was found between 6 to 7 years and 9 to 10 years (younger cohort) compared to between 12 to 13 years and 15 to 16 years (older cohort) (-0.38 diopter [D] and -0.13 D, respectively) (P<0.001). A statistically significantly greater change in AL was found among the younger compared to the older cohort (0.48 mm and 0.14 mm, respectively) (P<0.001). Change in ACD was minimal across both groups (0.12 mm younger and 0.05 mm older cohort) as were changes in CRC. Change in SER was associated with change in AL in both age groups (both P<0.01). There is a greater change in both spherical refractive error and axial length in younger children when compared with teenagers. Although increase in axial length drives refractive change during childhood and teenage years, lens compensation continues to occur in an attempt to maintain emmetropia. White children living in Northern Europe demonstrate dramatically less change in spherical refractive error over a fixed period of time than their East Asian counterparts. In contrast, they appear to exhibit more rapid myopic progression than UK children studied in the mid-20th century.

Long-term Changes in Refractive Error in Patients with Accommodative Esotropia

To evaluate changes in the spherical equivalent (SE) refractive error and astigmatism in Korean patients with accommodative esotropia. Retrospective cases series. A total of 111 patients with accommodative esotropia who received at least 2 years of follow-up after receiving prescription spectacles. Patients were divided into groups according to the age at which spectacles were prescribed (youngest, middle, and oldest age groups), initial degree of SE refractive error (lowest, moderate, and highest SE group), initial degree of astigmatism (least, moderate, and most astigmatic group), and presence of amblyopia (amblyopic or nonamblyopic). Changes in SE refractive error and astigmatism were compared between groups. Factors that significantly influenced changes in refractive error were analyzed using mixed linear models. Changes in SE refractive error and changes in astigmatism according to the duration of time after the initiation of wearing spectacles. Patients were followed up for a mean of 7.55 ± 3.59 years. Although an initial increase in SE was noted in the youngest-age group, an overall decreasing tendency in SE refractive error during the follow-up period was noted in the youngest (P < 0.01, mixed linear model), the middle (P < 0.01), and the oldest (P < 0.01) age groups. Amblyopic eyes showed greater decreases in SE compared with nonamblyopic eyes (P=0.01). The most hyperopic group showed the greatest decrease in hyperopia over time (P=0.01). The initial degree of hyperopia (P < 0.01) and amblyopia (P < 0.01) showed significant associations with changes in SE refractive error. The initial degree of astigmatism (P < 0.01) showed a significant association with changes in astigmatism. Patients with accommodative esotropia showed a continuous decrease in SE refractive error over time. Changes in refractive error in patients with accommodative esotropia may be influenced by both spectacle wearing and amblyopia. The author(s) have no proprietary or commercial interest in any materials discussed in this article.